Latest news from CTNZ

Our Vascular surgeon Dr Manar Khashram has been awarded the Te Whatu Ora Waikato Kudos Medical Scientist award 2023

One of the most prominent trials conducted by Dr Khashram and CTNZ includes the management of abdominal aortic aneurysms. Congratulations Dr Khashram from the team at CTNZ.

Prevision study with PI Dr Manar Khashram

Our Clinical Trials NZ vascular team has been conducting Prevision study with PI Dr Manar Khashram.

2023 ARCS Annual Conference (6 – 8 June 2023)

The 2023 ARCS Annual Conference (6 – 8 June 2023) will be held at the International Convention Centre (ICC), Darling Harbour, Sydney.

9th VERVE Symposium in Sydney in December


VEITHsymposium November 2022

49th Annual Symposium on Vascular and Endovascular Issues

Do you have Plaque Psoriasis?

Clinical Trials NZ is conducting a clinical trial of an investigational medication for moderate to severe Plaque Psoriasis.

Type 2 Diabetes Study

Type 2 Diabetes Study

Severe Rosacea Study

Do you suffer from Rosacea? Clinical Trials NZ in Hamilton is conducting a clinical trial with a new medication for people who have Rosacea (Red Flushing Face).

Upcoming NZ Acres 2017 Conference

The theme for the conference this year is “Innovation in Research and Clinical Trials”.

SABER™ Bupivacaine, a novel extended-release formulation of bupivacaine for postoperative pain control...

demonstrates dose-response, safety and no impact on surgical wound healing.

Intranasal Ketorolac (ROX-888) for Postoperative Pain: A Phase 3, Double-Blind, Randomized Study

Presented at the 2008 Society for Ambulatory Anesthesia Annual Meeting